AlfordR.
H.1965. An attempt at protection of man against virulent
influenza using nasal instillation of inactivated virus. Ann.
Int. Med., 62:1312–1314.
2.
Anon. “Accident
Prevention Regulations for Medical Laboratories.”. Berufsgenossenchaft fur Gesundheitsdienst und Wohfohrtspflege, Hamburg 36, Germany. 1956.
3.
Anon. Laboratory
Safety. National Center for Disease Control, Department of
Health, Education and Welfare. Publication No. HSM 72–8118, Atlanta, Georgia, April 1972.
4.
BirtC. & LambG.1899. Mediterranean or Malta fever. The Lancet (9
Sept):701–710. Also see Meyer, K. F. and Eddie, B. 1941. Laboratory infections due to
brucella. J. Infect. Dis., 68:24–32.
5.
CateT. R., CouchR. B., FleetW. F., GriffithW. R., GeroneP. J. & KnightV.1965. Production of tracheobronchitis in volunteers with
rhinovirus in a small particle aerosol. Amer. J.
Epidemiol., 81:95–105.
6.
ChatignyM.
A. & ClingerD.
I.1969. Contamination control in aerobiology. In: An Introduction to Experimental Aerobiology. Edited by DimmickR.L., AkersA.B.. John Wiley & Sons, Inc., New York,
NY, pp. 194–263.
7.
CouchR. B., CateT. R., DouglasR. G., GeroneP. J. & KnightV.1966a. Effect of route of inoculation on experimental
respiratory viral disease in volunteers and evidence for airborne
transmission. Bact. Reviews, 20(3):517–529.
8.
CouchR. B., CateT. R., FleetW. F., GeroneP. J. & KnightV.1966b. Aerosol-induced adenovirus illness resembling the
naturally-occurring illness in military recruits. Amer. Rev.
Resp. Dis., 93:529–535.
9.
CouchR. B., CateT. R., GeroneP. J., FleetW. F., LangD. J., GriffithW. R. & KnightV.1965. Production of illness with small-particle aerosol of
Coxsackie A21. J. Clin. Invest., 44:535–542.
10.
CouchR. B., ChanockR. M., CateT. R., LangD. J., KnightV. & HuebnerR.
J.1963. Immunization with types 4 and 7 adenovirus by selective
infection of the intestinal tract. Amer. Rev. Resp.
Dis., 88:394–403.
11.
DarlowH.
M.Safety in the microbiological laboratory. In: Methods in Microbiology. Edited by NorrisJ.
R., RibbonsD. W.. Academic Press. New York,
NY (1969): 169–204.
12.
DimmickR. L., ChatignyM. A., VoglW. F. & MeeganJ.
M.Naval Biomedical Research Laboratory, Oakland, California National Cancer
Institute, Contract S-57. Third SVCP Triannual Progress
Report, 1 June 1972. (To be submitted for publication in Appl. Microbiol.).
13.
DulbeccoR. & VogtM.1954. Plaque formation and isolation of pure lines with
poliomeylitis viruses. J. Exper. Med., 99:167–182.
14.
EndersJ. R., CohenS. & KaneL.
W.1945. Immunity in Mumps: II The development of
complement-fixing antibody and dermal hypersensitivity in human beings following
mumps. J. Exper. Med., 81(1): 119–135.
15.
Fort Detrick Case No. 329, a 2nd LT in
USAMRIID, 1958. (Details of 398 cases were sent in 1964 to the American Public Health Association Committee on Laboratory Infections). Note there were only 3 other cases of pipetting infections among
Detrick's 423: brucellosis in 1945, tularemia in 1948, salmonellosis in 1960 - a biochemist.
16.
GeroneP.
J.. 1966. Assessment of experimental and natural viral
aerosols. Bact. Reviews, 30(3):576–588 (see p. 587).
17.
GreenR. H., BalsamoM. R., GilesJ. P., FrugmanS. & MirickG.
S.1965. Amer. J. Dis. Child, 10:348–365.
18.
KaselJ. A., EvansH. E., SpickardA. & KnightV.1963. Conjunctivitis and enteric infection with adenoviruses
types 26 and 27. Responses to primary, secondary, and reciprocal
cross-challenges. Amer. J. Hyg., 77:265–282.
19.
KennyM.
T. & SabelF.
L.1968. Particle size distribution of Serratia marcescens
aerosols created during common laboratory procedures and simulated laboratory
accidents. Appl. Microbiol., 16(8):1146–1150.
20.
KisskaltK.1915. Laboratory infections with typhoid
bacilli. Zeitschrift fur Hygiene and
Infektionskrankheiten, 80:145–162. Also see PhillipsG.B.1965. Causal factors in microbiological laboratory accidents and infections. Misc. Publication 2. U.S. Army, Fort Detrick (AD-615–012N).
21.
KnightV. (Discussant). 1967. The minimal infective
dose, pp. 247–249. In Transmission
of Viruses by the Water Route. Edited by Gerald Berg. Interscience Publishers, Inc, New
York.
22.
KnightV.. 1963. Studies in volunteers with respiratory viral agents
(Suppl.). Amer. Rev. Resp. Dis., 88:135–174.
23.
KoprowskiH., NortonT. W., JervisG. A., NelsonT. L., ChadwickD. L., NelsenD. J. & MeyerK.F.1956. Clinical investigations on attenuated strains of
poliomyelitis virus. J. Amer. Med. Assn., 160:954–966.
24.
KravetzH. M., KnightV., ChanockR. M., MorrisJ. A., JohnsonK. M., RefkindD. & UtzJ.
P.1961. Respiratory syncytial virus. III. Production of illness
and clinical observation in adult volunteers. J. Amer. Med.
Assn., 176:657–663.
MarkhamF.
S.1962. Viral content and stability of live measles
vaccines. Amer. J. Dis. Child, 103:267–270.
27.
MorrisJ. A., JohnsonK. M., AulisioC. G., ChanockR. M. & KnightV.1961. Clinical and serologic responses of volunteers given
vacuolating virus (SV40) by respiratory route. Proc. Soc. Exptl.
Bio. Med., 168:56–59.
28.
OkunoY.1962. Vaccination with egg passage measles virus by
inhalation. Amer. J. Dis. Child, 103:211–214.
29.
a. Occupational Safety and Health Act of
1970. Public Law 91–596, 91st Congress, S. 2193, December 29, 1970 (Effective 28 April 1971). b. Recordkeeping Requirements under the Williams-Steiger
Occupational Safety and Health Act of 1970 (OSHA 2002). c. Selected Publications of the Occupational Safety and Health
Administration. June 1972. (OSHA 2019). Available from: Office
of Information Services, OSHA, U.S. Dept. of Labor, Washington, D.C. 20210.
30.
PhillipsG.
B.1961. Microbiological safety in U.S. and foreign
laboratories. Technical Study 35. U.S. Army Biological
Laboratories, Fort Detrick. Maryland (AD-268–635).
31.
PhillipsG.
B.1965. Causal factors in microbiological laboratory accidents and
infections. Table 2 Misc. Publ. 2. U.S. Army Biological
Laboratories, Fort Detrick, Maryland. 251 p. (AD-615–012N).
32.
PhillipsG.
B. & BaileyS.
P.1966. Hazards of mouth pipetting. Amer. J. Med. Technol., 32(2): 127–129.
33.
PikeR. M. Sulkin. S.
E. & ShulzeM.
L.1965. Continuing importance of laboratory-acquired
infections. Amer. J. Public Health, 55:190–199.
34.
PlotkinS. A., CornfieldD. & IngallsT.
H.1965. Studies of immunization with living rubella
virus. Amer. J. Dis. Child, 110:381–389.
35.
PlotkinS.
A. & KatzM.1967. Minimal infective doses of viruses for man by the oral
route, p. 151–166. In: Transmission of Viruses by the Water
Route. Edited by Gerald
Berg. Intersciences Publishers,
Inc., New York, 1967.
36.
ReinhardtF.1918. Prevention of laboratory infections. Zentralblatt fur Bakteriologie und Parasitologie, 80(7):456–465.
37.
RiesmanD.1898. Two cases of diphtheria, one from laboratory infection,
and one in an infant eleven days old. The Philadelphia Medical
Journal, 1(10):422–424.
38.
ReitmanM. & PhillipsG.
B.1955. Biological hazards of common laboratory procedures. I.
The Pipette. Amer. J. Med. Technol., 21:338–342.
39.
ShahK. V. & BaronS.1965. Laboratory infection with chikungunya virus: A case
report. Indian J. Med. Res., 53(7):610–613.
40.
ShawE. W., MelnickJ. L. & CurnenE.1950. Infection of laboratory workers with Coxsackie
viruses. Ann. Int. Med., 33: 32–40.
41.
SmithD. G., MamayH. K., MarshallR. G. & WagnerJ.
C.1956. Venezuelan equine encephalomyelitis: Laboratory aspects
of 14 human cases following vaccination and attempts to isolate the virus from the
vaccine. Amer. J. Hyg., 63:150–164.
42.
SouthamC.
M. & MooreA.
E.1954. Induced virus infections in many by the Egypt ioslates
of West Nile virus. Amer. J. Trop. Med. Hyg., 3:19–50.
43.
SulkinS.
E.Letter 4 Sept. 1969a. Department of
Microbiology, Southwestern Medical School, Dallas,
Texas: Unpublished data.
44.
SulkinS.
E. & PikeR. M.1969b. Prevention of laboratory infections, pp
66–78. In Diagnostic Procedures for Viral and Rickettsial
Infections. Edited by LennetteE. H., SchmidtN. J.. 4th Ed. American Public Health Association,
Inc, New York City.
45.
SulkinS. E., PikeR. M. & SchultzeM.
L.1963. Laboratory infections and accidents pp.
89–104. In HarrisAlbert
H. & ColemanMarion
B. (ed.) Diagnostic Procedures and
Reagents, 4th Ed. Amer. Public Health Assn.,
Inc., New York.
46.
SulkinS.
E. & PikeR. M.1951. Survey of laboratory-acquired
infections. Amer. J. Public Health, 41(7):769–781.
47.
SuttonL.
S. & BrookeC.
E.1954. Venezuelan equine encephalomyelitis due to vaccination
in man. J. Amer. Med. Assn., 155:1473–1476.
48.
Van den EndeM., HargreavesW. H., LocketS., NivenJ. & LennhoffL.1946. Accidental laboratory infection with tsutsugamushi
rickettsia. Lancet, 2:4–7.
49.
WedumA.
G.1950. Nonautomatic pipetting devices for the microbiological
laboratory. J. Lab. Clin. Med., 35:648–651.
50.
WedumA. G., BarkleyW. E. & HellmanA.1972. Handling of infectious agents. J. Amer. Vet. Med. Assn., 161(11):1557–1567.